GlassScriptPhysician profile
Paige C Walend
NPI 1750362513
$3,529.57
in general payments reported to CMS, 2019-2025
36 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $466 · 2020: $532 · 2021: $783 · 2022: $801 · 2023: $432 · 2024: $231 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $948.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $567.15 | 2019-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $553.83 | 2019-2021 | |
| Abbvie INC. | $337.31 | 2021-2025 | Qulipta, Vraylar |
| Lilly USA, LLC | $213.51 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $202.64 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Biohaven Pharmaceutical Holding Company LTD. | $155.92 | 2022 | |
| Abbott Laboratories | $151.51 | 2020-2023 | Proclaim |
| Janssen Pharmaceuticals, INC | $138.06 | 2019-2022 | |
| Pfizer INC. | $132.23 | 2019-2025 | |
| Dexcom, INC. | $130.69 | 2022-2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $100.92 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $92.18 | 2020-2022 | |
| Lucid Diagnostics INC. | $91.51 | 2021 | |
| Merck Sharp & Dohme LLC | $84.77 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.32 | 2021-2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $58.58 | 2019-2024 | Veozah |
| Topcon Healthcare Solutions, INC. | $49.35 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $48.10 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $32.94 | 2025 | Caplyta |
| Amarin Pharma, INC. | $31.56 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $30.60 | 2021-2022 | |
| Antares Pharma, INC. | $28.96 | 2020-2021 | |
| Upsher-Smith Laboratories LLC | $27.31 | 2020 | |
| Medtronic, INC. | $20.41 | 2023 | Intellis Adaptivestim |
| Allergan, INC. | $19.55 | 2020 | |
| Esperion Therapeutics, INC. | $18.83 | 2020 | |
| Gilead Sciences, INC. | $17.34 | 2022 | |
| Biotronik INC. | $16.04 | 2021 | |
| Amgen INC. | $15.59 | 2019 | |
| Impulse Dynamics (USA) INC. | $14.63 | 2024 | Optimizer |
| Clarus Therapeutics INC. | $14.37 | 2021 | |
| Paratek Pharmaceuticals, INC. | $13.78 | 2021 | |
| Boston Scientific Corporation | $13.75 | 2021 | |
| Exact Sciences Corporation | $13.35 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $12.96 | 2021 | |
| Medtronic USA, INC. | $12.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paige Walend listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.